111 related articles for article (PubMed ID: 28402196)
1. Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic Peptides Derived from E1/E2 Regions of Hepatitis C Virus.
Abdelhafez TH; Bader El Din NG; Tabll AA; Mashaly MM; Dawood RM; Yassin NA; El-Awady MK
Viral Immunol; 2017 Jun; 30(5):359-365. PubMed ID: 28402196
[TBL] [Abstract][Full Text] [Related]
2. Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus.
El-Awady MK; Tabll AA; Yousif H; El-Abd Y; Reda M; Khalil SB; El-Zayadi AR; Shaker MH; Bader El Din NG
Vaccine; 2010 Dec; 28(52):8338-44. PubMed ID: 19995542
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2.
El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK
Virol J; 2011 Aug; 8():391. PubMed ID: 21819575
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
[TBL] [Abstract][Full Text] [Related]
5. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
[TBL] [Abstract][Full Text] [Related]
6. Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.
Li D; von Schaewen M; Wang X; Tao W; Zhang Y; Li L; Heller B; Hrebikova G; Deng Q; Ploss A; Zhong J; Huang Z
J Virol; 2016 Dec; 90(23):10486-10498. PubMed ID: 27630242
[TBL] [Abstract][Full Text] [Related]
7. In vitro neutralization of HCV by goat antibodies against peptides encompassing regions downstream of HVR-1 of E2 glycoprotein.
Tabll AA; Atef K; Bader El Din NG; El Abd YS; Salem A; Sayed AA; Dawood RM; Omran MH; El-Awady MK
J Immunoassay Immunochem; 2014; 35(1):12-25. PubMed ID: 24063613
[TBL] [Abstract][Full Text] [Related]
8. Keyhole Limpet Hemocyanin-Conjugated Peptides from Hepatitis C Virus Glycoproteins Elicit Neutralizing Antibodies in BALB/c Mice.
Deng K; Xu Z; Chen M; Liu X
J Immunol Res; 2021; 2021():3108157. PubMed ID: 33532506
[TBL] [Abstract][Full Text] [Related]
9. Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro.
Tabll AA; Moustafa RI; El Abd YS; Bader El Din NG; El-Shenawy R; Yousef H; Hussein M; Dawood RM; Omran MH; El-Awady MK
J Immunoassay Immunochem; 2014; 35(1):60-73. PubMed ID: 24063617
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line.
Earnest-Silveira L; Chua B; Chin R; Christiansen D; Johnson D; Herrmann S; Ralph SA; Vercauteren K; Mesalam A; Meuleman P; Das S; Boo I; Drummer H; Bock CT; Gowans EJ; Jackson DC; Torresi J
J Gen Virol; 2016 Aug; 97(8):1865-1876. PubMed ID: 27147296
[TBL] [Abstract][Full Text] [Related]
11. Level of Human Antibodies Targeting HCV E1/E2 Peptides and Spontaneous Clearance of HCV in Blood Donors.
Tabll AA; Salem EA; El-Abd YS; El-Shenawy RM; Saad A; Abdallah SO; Dawood RM; El-Awady MK
Clin Lab; 2016 Oct; 62(10):1879-1885. PubMed ID: 28164540
[TBL] [Abstract][Full Text] [Related]
12. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
Deng K; Liu R; Rao H; Jiang D; Wang J; Xie X; Wei L
PLoS One; 2015; 10(9):e0138756. PubMed ID: 26406225
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag.
Sun W; Li Q; Zhu D; Feng J; Zhuang Z; Sun X; Xiao G; Duan Y
J Med Virol; 2015 Dec; 87(12):2090-7. PubMed ID: 26010499
[TBL] [Abstract][Full Text] [Related]
14. Novel adeno‑associated virus‑based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice.
Zhu F; Wang Y; Xu Z; Qu H; Zhang H; Niu L; Xue H; Jing D; He H
Mol Med Rep; 2019 Feb; 19(2):1016-1023. PubMed ID: 30569131
[TBL] [Abstract][Full Text] [Related]
15. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
[TBL] [Abstract][Full Text] [Related]
16. A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
Sasayama M; Shoji I; Adianti M; Jiang DP; Deng L; Saito T; Watanabe H; Kawata S; Aoki C; Hotta H
J Med Virol; 2012 Feb; 84(2):229-34. PubMed ID: 22170542
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
[TBL] [Abstract][Full Text] [Related]
18. Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats.
El-Awady MK; Tabll AA; El-Abd YS; Yousif H; Hegab M; Reda M; El Shenawy R; Moustafa RI; Degheidy N; El Din NG
Virol J; 2009 May; 6():66. PubMed ID: 19473491
[TBL] [Abstract][Full Text] [Related]
19. New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
Kachko A; Kochneva G; Sivolobova G; Grazhdantseva A; Lupan T; Zubkova I; Wells F; Merchlinsky M; Williams O; Watanabe H; Ivanova A; Shvalov A; Loktev V; Netesov S; Major ME
Vaccine; 2011 Dec; 30(1):69-77. PubMed ID: 22041300
[TBL] [Abstract][Full Text] [Related]
20. Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cells.
Tabll A; El Abd Y; El Din NG; El Shenawy R; Abdelhafez TH; El Awady M; El-Mohamady H; Viazov S
Hum Antibodies; 2013; 22(3-4):55-65. PubMed ID: 24961863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]